Plasma Lifting

Non-invasive skin-lifting skin-tightening face-rejuvenation collagen-inducing goodness

As we age, our skin produces less collagen, and the dermal layer thins and loses elasticity. Together these factors lead to sagging and wrinkling of skin.
Plasma Lifting is a non-surgical treatment that addresses skin conditions including: loss of elasticity, sagging and wrinkles. The Plasma Pen used in the procedure is an FDA-approved device used to perform “fibroblast therapy”, a technique used to stimulate the production of rejuvenating collagen.

It does this by converting electrical energy into gaseous diatomic molecular nitrogen and transmitting that energized gas to the skin’s surface from above without making physical contact, like a tiny lightning strike. When the plasma hits the skin it vaporizes any liquid in the skin at the point of contact, and causes a micro-trauma to the skin’s epidermal (top) layer, whilst simultaneously heating and disrupting the deeper dermal structure via thermal conduction.

plasma1 

Surrounding skin tightens around it, giving a shrinking and lifting effect as skin layers get vaporised by the plasma (via heating, fragmentation and vaporization). Tiny brown marks called “carbon crusts” visible after treatment flake away in 5-7 days, revealing new skin underneath. Skin fibroblasts get busy producing collagen and elastin, which gives a further tightening. Effects are visible right away, with full results after two weeks to a month.

Numbing cream can be used to minimize discomfort. Side effects are minimal and complications are rare.
There may be swelling for a few days after treatment around the eyes.
An additional procedure may be performed 6-8 weeks after the first one if required.

Ideal for the following conditions:

  • Accordion lines – “smile lines” outside of the mouth.
  • Acne scars – post-acne marks and scars can be smoothed
  • Crow’s feet -- lines around eyes can be softened
  • Forehead -- resting lines can be softened
  • Jowls/jawline -- skin can be tightened to improve jawlines
  • Marionette lines – those creases from mouth corners down the chin
  • Nasal labial folds – sides of your nose to the edge of mouth
  • Necklines -- can be used to tighten “turkey neck”
  • Smoker’s lines – vertical wrinkles around the mouth that suck lipstick
  • Stretch marks: boosting collagen improves appearance
  • Upper and lower eyelids – Bags and hoods

BOTOX® is a Prescription Medicine containing 100 units of botulinum toxin type A for injection. It is used for the treatment of frown lines, forehead lines and crow’s feet. Dysport® is a Prescription Medicine containing 500 units of Clostridium botulinumin toxin type A for injection. It is used for the treatment of Glabellar lines. They should be administered only by trained medical professionals. Ask your specialist about the benefits and risks of using Botox or Dysport and whether they are right for you. If you have any side effects or concerns speak to your health professional. You will need to pay for Botox and Dysport. They have benefits and risks. Always follow your specialist’s instructions. For more information refer to the Consumer Medicine Information for Botox or Dysport at www.medsafe.govt.nz BOTOX® is a registered trademark of Allergan, Inc. Allergan New Zealand Ltd, PO Box 1873, Shortland Street, Auckland 1140, New Zealand. Dysport is distributed by Pharmacy Retailing (NZ) Ltd t/a Healthcare Logistics P O Box 62027, Sylvia Park, Auckland 1644 BELKYRA® injection is a prescription medicine containing 10 mg/mL deoxycholic acid. It is used for the improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults. Do not use in people allergic to this medicine, with infection at site of injection, pregnancy and lactation. Possible side effects include headaches, difficulty swallowing, nausea, skin tightness, hypertension, injection site bruising/ pain/ swelling/ numbness/ redness/ tingling/ hardness/ itching/ discolouration/ formation of small areas of hardness/ warmth and injection site nerve injury.

BELKYRA® treatment is not funded on the New Zealand Pharmaceutical Schedule. You will need to pay for this medicine. Normal Doctors visit fees apply. BELKYRA® treatment should be administered only by trained medical professionals. Speak to your specialist about your own situation and about the benefits/risks of this procedure in appearance medicine. For further information, the Data Sheet and Consumer Medicines Information can be accessed at www.medsafe.govt.nz or ask your doctor. If you have any side effects or concerns speak to your doctor. Note: Results from BELKYRA® treatment usually last up to four years. BELKYRA® and its design are trademarks of Kythera Biopharmaceuticals, Inc., an Allergan affiliate. ™Trademark of Allergan, Inc. Allergan Australia Pty Ltd, 810 Pacific Highway, Gordon NSW 2072. ABN 85 000 612 831. Allergan New Zealand Limited, Auckland. © 2018 Allergan. All rights reserved.